Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation
Public company
Traded as NASDAQ: AGTC
Industry Biotechnology
Founded January 19, 1999 (1999-01-19)
Headquarters Alachua, Florida, United States
Key people
  • Susan B. Washer
  • (President & CEO)
  • William A. Sullivan
  • (CFO)
Revenue
  • Decrease US$ 39.47 million
  • (FY JUN 30 2017)
  • Increase US$ 1.90 million
  • (FY JUN 30 2017)
  • Increase US$ 0.41 million
  • (FY JUN 30 2017)
Total assets
  • Decrease US$ 147.92 million
  • (FY JUN 30 2017)
Total equity
  • Increase US$ 115.33 million
  • (FY JUN 30 2017)
Number of employees
  • 72
  • (FY JUN 30 2017)
Website AGTC.com
Footnotes / references
[1]

The Applied Genetic Technologies Corporation is a publicly traded (NASDAQ: AGTC)[2] biotechnology company that is part of the NASDAQ Biotechnology Index. It was founded in 1999 and has its headquarters in Alachua, Florida.[3]

The company focuses on ophthalmologic genetic diseases. The company's technologies are aimed at products that might have the potential to treat achromatopsia, X-linked retinoschisis,[4][5] X-linked retinitis pigmentosa,[6] and age-related macular degeneration.[7] The company has six products in various stages of development; as of 2016, none had yet been approved.[8]

References

  1. ↑ "US SEC: Form 10-K Applied Genetic Technologies Corporation". U.S. Securities and Exchange Commission. Retrieved April 8, 2018.
  2. ↑ "Applied Genetic Technologies Corporation (AGTC)". NASDAQ.com. Retrieved 4 January 2016.
  3. ↑ "Company Overview of Applied Genetic Technologies Corporation". Bloomberg. Retrieved November 15, 2016.
  4. ↑ Chen, Angela. "Biogen to Pay Applied Genetic $124 Million to Develop Eye-Disease Treatments". Wall Street Journal. Retrieved 4 January 2016.
  5. ↑ "AGTC Announces Data Evaluating the Natural History of Patients With X-Linked Retinoschisis at the 48th Annual Retina Society Meeting". Yahoo Finance. Retrieved 4 January 2016.
  6. ↑ "Biogen enters eye-treatment arena with AGTC deal". Reuters. 2 July 2015. Retrieved 4 January 2016.
  7. ↑ Ballie, Katherine. "Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia". www.upenn.edu. Retrieved 4 January 2016.
  8. ↑ "Finding Cures for Visual Disorders l Products". www.agtc.com. Retrieved 4 January 2016.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.